Pompiliu-Mircea Bogdan

Dr. Pompiliu-Mircea Bogdan


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2024 in Life
Verified
Journal Article
Open access
PDF file
FNFlorentina Nastase
Florentina Nastase
ANAlin Codrut Nicolescu
Alin Codrut Nicolescu
CBCAMELIA BUSILA
CAMELIA BUSILA
CMCristina Mihaela Marin
Cristina Mihaela Marin
RBRoxana-Elena Bogdan-Goroftei
Roxana-Elena Bogdan-Goroftei
Alin Laurentiu TATUAlin Laurentiu TATU
Alin Laurentiu TATU
Introduction: This study was carried out to demonstrate the negative influence that the COVID-19 pandemic had on the ability of patients to treat hyperhidrosis with iontophoresis. The purpose of this study is to identify the annual distribution of patients with hyperhidrosis as well as elaborate a curve of cases within the time interval studied. Methods: It is a retrospective study initiated in the Department of Neuropsychomotor Rehabilitation of the “Sf. Ioan” Emergency Clinical Hospital for Children, Galati, Romania, in which we analyzed the electronic database, the treatment, and the consultation files of all the children who presented between January 2013 and December 2023. We found 111 patients who met the inclusion criteria. Results: During the 3 years of the pandemic, the number of patients who came to our clinic suddenly dropped to 0. Limitations: This study was conducted on a relatively small number of patients in a Neuropsychomotor Recovery clinic. This study includes only patients with palmar and/or plantar hyperhidrosis who presented to the clinic for iontophoresis. Conclusion: Although it is a disease that significantly influences the quality of life, patients and their families do not consider hyperhidrosis to be an urgent problem that can be improved by treatment.

Verified
Journal Article
Open access
PDF file
PBPompiliu-Mircea Bogdan
Pompiliu-Mircea Bogdan
CSCamer Salim
Camer Salim
RBRoxana-Elena Bogdan-Goroftei
Roxana-Elena Bogdan-Goroftei
CPCatalin Plesea-Condratovici
Catalin Plesea-Condratovici
CGCristian Gutu
Cristian Gutu
ACAlina Mihaela Calin
Alina Mihaela Calin
Background/Objectives: Prognostication in ICU patients with documented coma or unresponsiveness is a high-stakes task that informs escalation of care, goals-of-care discussions, and family counselling. Conventional scores are often based on static snapshots and may not reflect early physiological evolution in heterogeneous real-world ICU populations. Routine arterial blood gases (ABG) and SpO2 are repeatedly measured during early ICU care and may capture clinically meaningful trajectories that can be leveraged by explainable machine learning. To develop and internally validate exploratory, time-updated explainable machine-learning models for ICU outcome in ICU patients with clinically documented coma or unresponsiveness using routine ABG/SpO2 measurements and physiological trajectories available at admission, 24 h, and 72 h, and to evaluate whether trajectory information adds prognostic information within a staged internal-validation framework. Methods: We conducted a retrospective single-centre study of 108 adult ICU patients with clinically documented coma or unresponsiveness. Predictors included demographics, comorbidity burden, COVID-19 status, baseline ABG/SpO2 at ICU admission, inflammatory and coagulation biomarkers, and derived ABG/SpO2 trajectory variables at 24 h and 72 h. Trajectory variables were defined as changes from admission to 24 h and to 72 h and were retained as missing when follow-up measurements were unavailable. The primary ICU-course outcome was ICU death versus transfer to ward. Three staged models were evaluated: Model A using baseline variables, Model B adding 24 h trajectory features, and Model C adding 72 h trajectory features. For each stage, models were analyzed with and without the derived respiratory_support index; models excluding respiratory_support were treated as the main interpretive analyses. Logistic regression, random forest, and gradient boosting (XGBoost) classifiers were assessed using repeated stratified 5-fold cross-validation with 20 repeats and aligned out-of-fold predictions. Performance was reported using AUC-ROC, precision–recall AUC, Brier score, and operating-point metrics; clinical utility was examined with decision-curve analysis. Model interpretation used SHAP and partial dependence plots. Robustness analyses included feature-exclusion sensitivity analysis for respiratory_support and a label-permutation sanity check. Results: ICU mortality was 65.7% (71/108). Follow-up ABG completeness was 75.9% at 24 h and 61.1% at 72 h. Because respiratory_support summarized the highest support level during the first 72 h and strongly separated outcome groups, models excluding respiratory_support were treated as the primary interpretive analyses. In the primary NoRS logistic-regression models, discrimination was moderate-to-strong, with AUC-ROC 0.822 for Model A_noRS, 0.848 for Model B_noRS, and 0.895 for Model C_noRS; bootstrap 95% confidence intervals were 0.739–0.897, 0.766–0.919, and 0.830–0.951, respectively. Measurement-availability sensitivity analyses and simple benchmark models were added to contextualize trajectory-related performance. Respiratory_support-enriched models were retained only as secondary severity-aware analyses, not as admission-only prediction models. Label permutation reduced discrimination toward chance (AUC ≈ 0.55). SHAP and partial-dependence analyses identified oxygenation variables, inflammatory burden, acid–base status, and ΔPaO2 at 72 h as clinically coherent contributors to predicted risk; when included, respiratory_support dominated feature attribution, consistent with its role as an organ-support intensity marker. Conclusions: In ICU patients with clinically documented coma or unresponsiveness, explainable machine-learning models using routine ABG/SpO2 trajectories within the first 72 h are feasible and may provide time-updated prognostic information, but the incremental value of trajectory-enriched models over simpler admission-only benchmarks remains unproven. Trajectory-enriched NoRS models retained meaningful discrimination after removing organ-support severity, suggesting a possible physiologically meaningful signal beyond support intensity alone, although definitive incremental value over parsimonious admission-only benchmarks was not established. These findings should be interpreted as exploratory and internally validated only; they do not establish a deployable ICU mortality score, do not demonstrate superiority over established ICU severity scores, and require external validation in larger multicentre cohorts before clinical deployment.

11 August 2026 in Diseases
Verified
Journal Article
Open access
PDF file
MAManuela Arbune
Manuela Arbune
PNPantelie Nicolcescu
Pantelie Nicolcescu
ACAnamaria Ciubara
Anamaria Ciubara
PBPompiliu-Mircea Bogdan
Pompiliu-Mircea Bogdan
CVCONSTANTIN MARINEL VLASE
CONSTANTIN MARINEL VLASE
AAAnca-Adriana Arbune
Anca-Adriana Arbune
Background/Objectives: Neuroinflammation is increasingly recognized as a key mechanism linking infectious diseases with psychiatric disorders through interactions between peripheral immune activation, metabolic pathways, and brain network alterations. This review aimed to synthesize current evidence on the neuroimmune mechanisms and biomarkers underlying infection-associated psychiatric disorders. Methods: A narrative literature review structured according to the SANRA (Scale for the Assessment of Narrative Review Articles) criteria was conducted using the Web of Science Core Collection, PubMed/MEDLINE, Scopus and PsycINFO databases. Boolean search strategies identified studies investigating neuroinflammatory biomarkers, neuroimmune mechanisms, and psychiatric outcomes associated with infectious diseases. The search (January 2022–30 June 2026) included 76 studies in the final qualitative analyses. Results: The reviewed evidence consistently identified inflammatory cytokines and chemokines, complement proteins, blood–brain barrier markers, glial activation biomarkers, neuroaxonal injury markers, kynurenine pathway metabolites, neurotrophic factors, and neuroimaging markers as complementary indicators of infection-induced neuroimmune dysfunction. Across diverse bacterial, viral, parasitic, and systemic infections, these mechanisms converged on peripheral immune activation, blood–brain barrier disruption, microglial activation, kynurenine pathway dysregulation, impaired neurotrophic signaling, synaptic dysfunction, and altered brain network connectivity, contributing to depression, anxiety, psychosis, cognitive impairment, and fatigue. Based on these findings, a unified neuroimmune model integrating peripheral and central mechanisms is proposed. Conclusions: Neuroinflammation emerges as a shared biological pathway linking infections with transdiagnostic psychiatric phenotypes. Although no single biomarker currently demonstrates sufficient diagnostic specificity, integrated multimodal biomarker panels may improve biological stratification, facilitate earlier identification of high-risk patients, and support the development of mechanism-based precision approaches—including candidate anti-inflammatory pharmacological strategies currently under clinical investigation—for infection-associated psychiatric disorders.

7 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
PBPompiliu-Mircea Bogdan
Pompiliu-Mircea Bogdan
CPCatalin Plesea-Condratovici
Catalin Plesea-Condratovici
RBRoxana-Elena Bogdan-Goroftei
Roxana-Elena Bogdan-Goroftei
LDLetitia Doina Duceac
Letitia Doina Duceac
AAAdina Oana Armencia
Adina Oana Armencia
ACAlina Mihaela Calin
Alina Mihaela Calin
Background/Objectives: Comatose patients admitted to intensive care represent a heterogeneous critical population, in which prognosis can be influenced by the interaction between inflammation, coagulation, tissue damage and respiratory dysfunction. This study aimed to identify physiological phenotypes in comatose ICU patients and evaluate their association with ICU outcome. Methods: A retrospective observational study was performed on 227 adult comatose patients admitted to the ICU. Clinical variables, inflammatory and coagulation markers, LDH, blood gas parameters, APACHE and SOFA scores and ICU outcome were analyzed. Spearman correlations, hierarchical cluster analysis, Kruskal–Wallis tests, Dunn post hoc, effect sizes and adjusted logistic regression were used. Results: ICU mortality was 65.6%. Cluster analysis suggested three tentative phenotypes: inflammatory–coagulopathic, relatively stable, and a severe respiratory–inflammatory profile. Differences between clusters were mainly determined by D-dimers, CRP, procalcitonin, INR, and LDH, while APACHE and SOFA scores did not differ significantly between phenotypes. ICU outcome differed significantly between clusters (χ2 = 18.370; p < 0.001; Cramer’s V = 0.284), with the maximum mortality in Cluster 3. After adjustment, cluster membership did not remain an independent predictor of mortality. Conclusions: Comatose patients admitted to the ICU can be classified into exploratory physiological phenotypes, associated with different clinical outcomes in the unadjusted analysis. These results support the utility of multidimensional biological assessment but require external validation before clinical application.

3 May 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
PBPompiliu-Mircea Bogdan
Pompiliu-Mircea Bogdan
RBRoxana-Elena Bogdan-Goroftei
Roxana-Elena Bogdan-Goroftei
CPCatalin Plesea-Condratovici
Catalin Plesea-Condratovici
AAAdina Oana Armencia
Adina Oana Armencia
LDLetitia Doina Duceac
Letitia Doina Duceac
ACAlina Mihaela Calin
Alina Mihaela Calin
Background: Intensive care units (ICUs) provide management of critically ill patients requiring continuous monitoring and complex therapeutic interventions. The aim of this study was to analyze the clinical and biological characteristics associated with mortality in patients admitted to the intensive care unit. Methods: This retrospective observational study included 108 adult patients admitted to the Anesthesia and Intensive Care Unit of the “Sf. Apostol Andrei” Emergency County Clinical Hospital in Galați, who were in a coma at the time of admission. Demographic data, comorbidities, clinical parameters and biological biomarkers determined at admission were analyzed. Statistical analysis was performed using the SPSS program and included non-parametric tests (Mann–Whitney U), Spearman correlation analysis, multivariate logistic regression and ROC curve analysis to evaluate the predictive performance of biomarkers. Results: Hypertension (60.2%) and diabetes mellitus (35.2%) were the most common comorbidities. Comparative analysis revealed significant differences between deceased and surviving patients for several biological parameters, including leukocytes, C-reactive protein, LDH, D-dimers, INR and APTT. In multivariate analysis, LDH (OR = 0.998; p < 0.001) and APTT (OR = 0.951; p = 0.033) remained independently associated with mortality. ROC analysis revealed good discrimination capacity for LDH (AUC ≈ 0.805) and moderate performance for APTT. Conclusions: Determination of LDH and APTT at the time of admission to the ICU may provide useful information for assessing the prognosis of critically ill patients and for early stratification of mortality risk.

16 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MAManuela Arbune
Manuela Arbune
PNPantelie Nicolcescu
Pantelie Nicolcescu
ACAnamaria Ciubara
Anamaria Ciubara
PBPompiliu-Mircea Bogdan
Pompiliu-Mircea Bogdan
CVCONSTANTIN MARINEL VLASE
CONSTANTIN MARINEL VLASE
AAAnca-Adriana Arbune
Anca-Adriana Arbune
Background/Objectives: Neuroinflammation is increasingly recognized as a key mechanism linking infectious diseases with psychiatric disorders through interactions between peripheral immune activation, metabolic pathways, and brain network alterations. This review aimed to synthesize current evidence on the neuroimmune mechanisms and biomarkers underlying infection-associated psychiatric disorders. Methods: A narrative literature review was conducted using the Web of Science Core Collection, PubMed/MEDLINE, Scopus and PsycINFO databases. Boolean search strategies identified studies investigating neuroinflammatory biomarkers, neuroimmune mechanisms, and psychiatric outcomes associated with infectious diseases. The search (2022–June 2025) included 71 studies in the final qualitative analyses. Results: The reviewed evidence consistently identified inflammatory cytokines and chemokines, complement proteins, blood–brain barrier markers, glial activation biomarkers, neuroaxonal injury markers, kynurenine pathway metabolites, and neuroimaging markers as complementary indicators of infection-induced neuroimmune dysfunction. Across diverse bacterial, viral, parasitic, and systemic infections, these mechanisms converged on peripheral immune activation, blood–brain barrier disruption, microglial activation, kynurenine pathway dysregulation, synaptic dysfunction, and altered brain network connectivity, contributing to depression, anxiety, psychosis, cognitive impairment, and fatigue. Based on these findings, a unified neuroimmune model integrating peripheral and central mechanisms is proposed. Conclusions: Neuroinflammation emerges as a shared biological pathway linking infections with transdiagnostic psychiatric phenotypes. Although no single biomarker currently demonstrates sufficient diagnostic specificity, integrated multimodal biomarker panels may improve biological stratification, facilitate earlier identification of high-risk patients, and support the development of mechanism-based precision approaches for infection-associated psychiatric disorders.